Catalys Pacific, LLC

Updated 6 days ago

Managed by Catalys Pacific, Llc • Latest filing Q3 2026

Portfolio value

$209.7M

Q3 2026

Filings

Quarterly 13F history

Top-10 concentration

100.0%

Weight of largest holdings

Annualized return

—

Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 5 quarters

Show data table

2 positions as of Q3 2026

#	Stock	Value	Shares	% Portfolio	Change
1	M MLYS History → Mineralys Therapeutics, Inc.	$196M	7.80M	93.45%	—
2	P PHAT History → Phathom Pharmaceuticals, Inc.	$13.7M	1.88M	6.55%	—

Mineralys Therapeutics, Inc.

Value

$196M

7.80M

% Port

93.45%

Phathom Pharmaceuticals, Inc.

Value

$13.7M

1.88M

% Port

6.55%